Live
Home·Deals·Life Sciences·Efor acquires No deviation
SEO URLwww.firestrike.ai/deals/no-deviation-efor-acquisition-2026
acquisitionAnnounced · Mar 3, 2026Life SciencesSource · CredibleArticle · Factual
No deviation
Efor
No deviation · Efor

Efor acquires No deviation

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
No deviation
No deviation
Singapore, Central Singapore
Acquirer
Efor
Efor
Full Acquisition
Status
Announced

Efor agreed to acquire No deviation. Reported deal value: Undisclosed. Status: Announced. Sector: Life Sciences. Target headquarters context: Singapore, Central Singapore, Singapore.

This page summarizes publicly available information about the transaction as of 2026-03-03. Figures and status may change as filings and press coverage update.

March 3, 20 26 /PRNewswire/ — Efor , a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore -based No deviation , a company recognized for its expertise in Commissioning, Qualification & Validation , Computer System Validation , Quality Compliance and Digital Enablement

Deal timeline

Announced
Mar 3, 2026 · weeklyvoice.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Life Sciences. Figures and status may change as sources update.

Sources: weeklyvoice.com · Primary article · FireStrike proprietary index